SCHEMBL7657562

SCHEMBL7657562

COc1ccc2c(c1OC)C[C@H](C(=O)O)N2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 2/20 0.44
TP53 P04637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
GAA P10253 1/20 0.43
ACHE P22303 3/20 0.42
ALOX12 P18054 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657575 1.00 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL5564125 0.87 ACHE (0.41) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL24112504 0.85 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL27536992 0.82 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL926564 0.81 DRD2 (0.52) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL7660514 0.81 DRD2 (0.52) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
1,2-Dimethoxybenzene SCHEMBL27572044 0.78 GAA (0.53) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
SCHEMBL7036768 0.78 MEN1 (0.43) ALDH1A1HPGDMEN1KMT2ACYP2D6
SCHEMBL27904690 0.72 MAPT (0.51) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53
Hydrochloric Acid SCHEMBL10908879 0.71 MAPT (0.50) ALDH1A1SMN1; SMN2HPGDCYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403561-B1 DISORDERS ASSOCIATED WITH THE INACTIVATION OR EXCESSIVE DEGRADATION OF CHOLECYSTOKININ; INHIBITING THE ENZYMATIC HYDROLYSIS OF CHOLECYSTOKININ 1-(2(S)-AMINOBUTYRYL)-2(S)-INDOLINECARBOXYLIC ACID INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-06-11 US disclosed